{
    "2019-08-26": [
        [
            {
                "time": "",
                "original_text": "康龙化成：发行H股申请材料获中国证监会受理",
                "features": {
                    "keywords": [
                        "康龙化成",
                        "H股",
                        "证监会",
                        "受理"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "康龙化成：发行境外上市外资股事项获证监会受理",
                "features": {
                    "keywords": [
                        "康龙化成",
                        "境外上市",
                        "外资股",
                        "证监会",
                        "受理"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "【川财研究所*四季度展望】医药生物：板块迎来估值切换，关注四季度业绩优异个股",
                "features": {
                    "keywords": [
                        "川财研究所",
                        "医药生物",
                        "估值切换",
                        "四季度",
                        "业绩优异"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "社保基金新入63股，重点布局电子和医药股",
                "features": {
                    "keywords": [
                        "社保基金",
                        "电子",
                        "医药股",
                        "布局"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "电子",
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}